Literature DB >> 2877857

Long term outcome of treatment with sulphasalazine in rheumatoid arthritis.

R D Situnayake, B McConkey.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2877857     DOI: 10.2165/00003495-198600321-00015

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  6 in total

1.  A biochemical assessment of sulphasalazine in rheumatoid arthritis.

Authors:  H A Bird; J S Dixon; M E Pickup; V M Rhind; J R Lowe; M R Lee; V Wright
Journal:  J Rheumatol       Date:  1982 Jan-Feb       Impact factor: 4.666

2.  An overview of benefit/risk of disease modifying treatment of rheumatoid arthritis as of today.

Authors:  H E Paulus
Journal:  Ann Rheum Dis       Date:  1982       Impact factor: 19.103

3.  Outcome of attempts to treat rheumatoid arthritis with gold, penicillamine, sulphasalazine, or dapsone.

Authors:  K A Grindulis; B McConkey
Journal:  Ann Rheum Dis       Date:  1984-06       Impact factor: 19.103

4.  Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.

Authors:  V C Neumann; K A Grindulis; S Hubball; B McConkey; V Wright
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-15

5.  Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate.

Authors:  T Pullar; J A Hunter; H A Capell
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-15

6.  Sulphasalazine: a safe, effective agent for prolonged control of rheumatoid arthritis. A comparison with sodium aurothiomalate.

Authors:  D E Bax; R S Amos
Journal:  Ann Rheum Dis       Date:  1985-03       Impact factor: 19.103

  6 in total
  1 in total

1.  Prospective trial comparing the use of sulphasalazine and auranofin as second line drugs in patients with rheumatoid arthritis.

Authors:  D Porter; R Madhok; J A Hunter; H A Capell
Journal:  Ann Rheum Dis       Date:  1992-04       Impact factor: 19.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.